š° Met High News
Met High News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Met High. Real-time updates on events, politics, business and more.
February 2, 2024
Reports Full-Year Diluted EPS of $2.72 on a GAAP Basis, a Decrease of 59.0 Percent; Adjusted Diluted EPS of $11.11, a Decrease of 19.3 Percent; These Results...
November 29, 2023
/PRNewswire/ -- AbbVie (NYSE: ABBV) announced today topline results from the single-arm Phase 2 LUMINOSITY trial evaluating telisotuzumab-vedotin (Teliso-V) in...
November 29, 2023
AbbVie Inc (NYSE: ABBV) announced topline results from the single-arm Phase 2 LUMINOSITY trial evaluating telisotuzumab-vedotin (Teliso-V) in patients with c-Met protein overexpression, epidermal growth factor receptor (EGFR) wild type, 
November 29, 2023
Biopharmaceutical company AbbVie, Inc. (ABBV) announced Wednesday topline results from the single-arm Phase 2 LUMINOSITY trial evaluating telisotuzumab-vedotin (Teliso-V) in patients with c-Met protein overexpression, epidermal growth factor receptor (EGFR) wild type, advanced/metastatic nonsquamous non-small cell lung cancer (NSCLC).
May 5, 2021
Wila Matos KINGSTON, R.I. ā May 5, 2021 ā University of Rhode Island senior Wila Matos of Providence has participated in community service projects in Atlanta and Baltimore, studied Portuguese, sustainability and fisheries in Cape Verde, and mentored high school students at The Met High School. Now she is preparing to spend nine months in Brazil as the recipient of a Fulbright fellowship. āIām super excited and honored to be a Fulbright finalist,ā said Matos, speaking from Cape Verd...